Medical Devices Startups

CREWT develops medical devices and services leveraging optical technology, with a focus on glaucoma detection and management in ophthalmology. The company aims to improve quality of vision and early detection of glaucoma, which is the leading cause of blindness.

1 investor

Crextremity develops the miniBunion 3D, a minimally-invasive surgical procedure for bunion correction that uses a micro-implant to realign the toe in three dimensions through a small incision. The procedure is designed for patients seeking faster recovery and reduced pain compared to traditional bunion surgery.

1 investor

Cristcot is a pharmaceutical development and medical device company focused on drug formulations, device engineering, and clinical development. The company advances innovative science from concept through regulatory approval and commercialization.

1 investor

Crosscope develops AI and machine learning technology for cancer screening and pathology diagnosis. The company provides computer-assisted diagnostic imaging analysis and automated image analysis tools for pathologists to improve workflow efficiency and diagnostic accuracy.

1 investor

Crossfire Oncology develops kinase inhibitors, degraders, and degrader antibody conjugates targeting cancer and other cellular proliferation disorders using proprietary EPriL chemistry. The company serves oncology markets with a pipeline including BAL0891, a clinical-stage dual TTK/PLK1 inhibitor.

1 investor

CORE Linen Services (formerly Crothall Laundry Services) provides healthcare linen and laundry processing for hospitals, outpatient facilities, and surgery centers. Operating since 1991 across the United States, it holds Hygienically Clean, HLAC, and LEED certifications.

1 investor

Cruinn Diagnostics is an Irish distributor of laboratory supplies, diagnostic equipment, and calibration services for clinical, pharmaceutical, veterinary, university, and research institutions. The company maintains a portfolio of over 1,000 products spanning microbiology, immunoassay, blood collection systems, and laboratory instrumentation.

1 investor

CrutchGecko makes accessories that attach to crutches to address common usability issues, including magnetic clips to prevent sliding, wrist straps for hands-free carrying, and multifunctional hooks. The products are designed for people using crutches who need better functionality and stability.

1 investor

CryoTherapeutics is developing a device-based treatment for vulnerable (high-risk) atherosclerotic plaque in the coronary arteries, a condition associated with coronary artery disease and heart attacks. The company targets a gap in cardiac care where existing options such as stents do not address the underlying plaque pathology.

1 investor

Constitution Surgery Alliance develops and operates ambulatory surgery centers through partnership models with surgeons and health systems. The company provides turnkey development, management services, and business intelligence tools to support outpatient surgery center operations.

1 investor

A medical company focused on in-house research and product development for the healthcare/medical device industry, with a stated global market presence. The page provides limited concrete detail about its specific products.

1 investor

CU Medical provides AED (automated external defibrillator) devices and remote monitoring systems for emergency medical response. The company serves healthcare facilities and organizations requiring emergency preparedness and real-time device monitoring.

1 investor

Cubby Beds manufactures safety beds designed for individuals with medical or developmental needs, selling directly to consumers and families through multiple funding pathways including insurance, payment plans, and financial assistance programs.

1 investor

CuePath develops smart stickers that attach to medication blister packs to monitor and record real-time adherence data for clinical drug trials. The technology targets clinical research organizations and serves substance use disorder and addiction management studies across North America.

1 investor

Cullgen is a privately held biopharmaceutical company developing first-in-class drugs based on its uSMITE™ (small-molecule induced ubiquitin-dependent target elimination) targeted protein degradation platform, which uses the ubiquitin-proteasome system and E3 ubiquitin ligases to target disease-causing proteins that conventional small-molecule drugs cannot reach. The company focuses on oncology and immune-related diseases and operates R&D and offices in both China and the United States.

1 investor

Curatia Medical develops and manufactures FDA and CE-approved disposable medical devices for interventional procedures in cardiology, peripheral, neurology, and pulmonology. The company serves healthcare providers globally through its own brands and OEM manufacturing partnerships.

1 investor

Curato matches Norwegian patients with private X-ray clinics for radiological services including MR, CT, and mammography. The platform aggregates pricing and quality information to help patients find affordable diagnostic imaging providers outside the public healthcare system.

1 investor

Curavit designs and executes decentralized clinical trials using technology to improve patient outcomes and trial efficiency for pharmaceutical and medical device companies.

1 investor

CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.

1 investor

CureMatch provides a digital decision support system that guides oncologists in selecting personalized cancer drug treatments based on individual patients' molecular tumor profiles.

1 investor

CUREOSITY develops CUREO, a virtual reality therapy system used in rehabilitation institutions to treat patients with motorsensory and cognitive impairments. The company serves clinics and practices, primarily in Germany but also globally, within the digital health and medtech sector.

1 investor

Curesign is a medical device company developing a system that combines sensors with signal processing and big data tools to help oncologists tailor patient-specific cancer treatments. Its technology has been demonstrated in preclinical studies and is being developed into a commercial product for oncology trials.

1 investor

Curestream develops an artificial pancreas system for diabetes management, combining an AI insulin control algorithm, modular insulin pump, and blood glucose management app to automate insulin delivery without user intervention.

1 investor

Cureus is an open-access medical journal platform that publishes peer-reviewed research. The platform uses technology and structured workflows to accelerate the peer review and publication process for medical research across all specialties.

1 investor